198 related articles for article (PubMed ID: 19678953)
1. Archaeosomes made of Halorubrum tebenquichense total polar lipids: a new source of adjuvancy.
Gonzalez RO; Higa LH; Cutrullis RA; Bilen M; Morelli I; Roncaglia DI; Corral RS; Morilla MJ; Petray PB; Romero EL
BMC Biotechnol; 2009 Aug; 9():71. PubMed ID: 19678953
[TBL] [Abstract][Full Text] [Related]
2. Archaeosomes display immunoadjuvant potential for a vaccine against Chagas disease.
Higa LH; Corral RS; Morilla MJ; Romero EL; Petray PB
Hum Vaccin Immunother; 2013 Feb; 9(2):409-12. PubMed ID: 23291939
[TBL] [Abstract][Full Text] [Related]
3. Archaeosome vaccine adjuvants induce strong humoral, cell-mediated, and memory responses: comparison to conventional liposomes and alum.
Krishnan L; Dicaire CJ; Patel GB; Sprott GD
Infect Immun; 2000 Jan; 68(1):54-63. PubMed ID: 10603368
[TBL] [Abstract][Full Text] [Related]
4. A structural comparison of the total polar lipids from the human archaea Methanobrevibacter smithii and Methanosphaera stadtmanae and its relevance to the adjuvant activities of their liposomes.
Sprott GD; Brisson J; Dicaire CJ; Pelletier AK; Deschatelets LA; Krishnan L; Patel GB
Biochim Biophys Acta; 1999 Sep; 1440(2-3):275-88. PubMed ID: 10521711
[TBL] [Abstract][Full Text] [Related]
5. Liposome adjuvants prepared from the total polar lipids of Haloferax volcanii, Planococcus spp. and Bacillus firmus differ in ability to elicit and sustain immune responses.
Sprott GD; Dicaire CJ; Gurnani K; Deschatelets LA; Krishnan L
Vaccine; 2004 Jun; 22(17-18):2154-62. PubMed ID: 15149772
[TBL] [Abstract][Full Text] [Related]
6. Safety of archaeosome adjuvants evaluated in a mouse model.
Patel GB; Omri A; Deschatelets L; Sprott GD
J Liposome Res; 2002 Nov; 12(4):353-72. PubMed ID: 12519630
[TBL] [Abstract][Full Text] [Related]
7. Halorubrum rubrum sp. nov., an extremely halophilic archaeon from a Chinese salt lake.
Qiu XX; Zhao ML; Han D; Zhang WJ; Cui HL
Antonie Van Leeuwenhoek; 2013 Nov; 104(5):885-91. PubMed ID: 23949820
[TBL] [Abstract][Full Text] [Related]
8. Halorubrum halophilum sp. nov., an extremely halophilic archaeon isolated from a salt-fermented seafood.
Yim KJ; Cha IT; Lee HW; Song HS; Kim KN; Lee SJ; Nam YD; Hyun DW; Bae JW; Rhee SK; Seo MJ; Choi JS; Choi HJ; Roh SW; Kim D
Antonie Van Leeuwenhoek; 2014 Mar; 105(3):603-12. PubMed ID: 24442192
[TBL] [Abstract][Full Text] [Related]
9. Archaeosomes varying in lipid composition differ in receptor-mediated endocytosis and differentially adjuvant immune responses to entrapped antigen.
Sprott GD; Sad S; Fleming LP; Dicaire CJ; Patel GB; Krishnan L
Archaea; 2003 Oct; 1(3):151-64. PubMed ID: 15803661
[TBL] [Abstract][Full Text] [Related]
10. Ultradeformable archaeosomes as new topical adjuvants.
Higa LH; Schilrreff P; Perez AP; Iriarte MA; Roncaglia DI; Morilla MJ; Romero EL
Nanomedicine; 2012 Nov; 8(8):1319-28. PubMed ID: 22366598
[TBL] [Abstract][Full Text] [Related]
11. Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines.
Patel GB; Zhou H; Ponce A; Chen W
Vaccine; 2007 Dec; 25(51):8622-36. PubMed ID: 17959279
[TBL] [Abstract][Full Text] [Related]
12. Halorubrum salsamenti sp. nov., a Novel Halophilic Archaeon Isolated from a Brine of Salt Mine.
Chen S; He J; Zhang J; Xu Y; Huang J; Ke LX
Curr Microbiol; 2017 Nov; 74(11):1358-1364. PubMed ID: 28819743
[TBL] [Abstract][Full Text] [Related]
13. Archaeobacterial ether lipid liposomes (archaeosomes) as novel vaccine and drug delivery systems.
Patel GB; Sprott GD
Crit Rev Biotechnol; 1999; 19(4):317-57. PubMed ID: 10723627
[TBL] [Abstract][Full Text] [Related]
14. Halorubrum yunnanense sp. nov., isolated from a subterranean salt mine.
Chen S; Liu HC; Zhao D; Yang J; Zhou J; Xiang H
Int J Syst Evol Microbiol; 2015 Dec; 65(12):4526-4532. PubMed ID: 26374710
[TBL] [Abstract][Full Text] [Related]
15. Halorubrum halodurans sp. nov., an extremely halophilic archaeon isolated from a hypersaline lake.
Corral P; de la Haba RR; Sánchez-Porro C; Ali Amoozegar M; Thane Papke R; Ventosa A
Int J Syst Evol Microbiol; 2016 Jan; 66(1):435-444. PubMed ID: 26537912
[TBL] [Abstract][Full Text] [Related]
16. In vitro evaluation of archaeosome vehicles for transdermal vaccine delivery.
Jia Y; McCluskie MJ; Zhang D; Monette R; Iqbal U; Moreno M; Sauvageau J; Williams D; Deschatelets L; Jakubek ZJ; Krishnan L
J Liposome Res; 2018 Dec; 28(4):305-314. PubMed ID: 28948854
[TBL] [Abstract][Full Text] [Related]
17. Sulfated archaeal glycolipid archaeosomes as a safe and effective vaccine adjuvant for induction of cell-mediated immunity.
McCluskie MJ; Deschatelets L; Krishnan L
Hum Vaccin Immunother; 2017 Dec; 13(12):2772-2779. PubMed ID: 28537465
[TBL] [Abstract][Full Text] [Related]
18. Halorubrum depositum sp. nov., a Novel Halophilic Archaeon Isolated from a Salt Deposit.
Chen S; Sun S; Xu Y; Lv J; Chen L; Liu L
Curr Microbiol; 2018 Jun; 75(6):677-683. PubMed ID: 29322241
[TBL] [Abstract][Full Text] [Related]
19. Archaeosomes as self-adjuvanting delivery systems for cancer vaccines.
Krishnan L; Dennis Sprott G;
J Drug Target; 2003; 11(8-10):515-24. PubMed ID: 15203920
[TBL] [Abstract][Full Text] [Related]
20. Sulfated archaeol glycolipids: Comparison with other immunological adjuvants in mice.
Akache B; Stark FC; Jia Y; Deschatelets L; Dudani R; Harrison BA; Agbayani G; Williams D; Jamshidi MP; Krishnan L; McCluskie MJ
PLoS One; 2018; 13(12):e0208067. PubMed ID: 30513093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
